NO20054642L - Ekspresjonsvektorer omfattende MCMV IE2 promoteren - Google Patents

Ekspresjonsvektorer omfattende MCMV IE2 promoteren

Info

Publication number
NO20054642L
NO20054642L NO20054642A NO20054642A NO20054642L NO 20054642 L NO20054642 L NO 20054642L NO 20054642 A NO20054642 A NO 20054642A NO 20054642 A NO20054642 A NO 20054642A NO 20054642 L NO20054642 L NO 20054642L
Authority
NO
Norway
Prior art keywords
mcmv
promoter
expression vectors
gene
expression
Prior art date
Application number
NO20054642A
Other languages
English (en)
Other versions
NO333818B1 (no
Inventor
Philippe Chatellard
Markus Imhof
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20054642L publication Critical patent/NO20054642L/no
Publication of NO333818B1 publication Critical patent/NO333818B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C07K14/04—Varicella-zoster virus
    • C07K14/045—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron
    • C12N2830/205—Vector systems having a special element relevant for transcription transcription of more than one cistron bidirectional
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives en ekspresjonsvektor omfattende promoteren av meMV-IE2 genet, eller et fimksjonelt, ekspresjonsfremmende fragment derav, og/eller en enhancer av meMV-IE2 genet, eller fimksjonelt, ekspresjonsfremmende fragment derav, der ekspresjonsvektoren ikke inneholder noe komplett gen av meMV.
NO20054642A 2003-03-11 2005-10-10 Ekspresjonsvektorer omfattende mCMV IE2 promoter, vertcelle inneholdende nevnte vektorer, anvendelses av vektorene samt fremgangsmåte for fremstilling av et polypeptid NO333818B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03100617 2003-03-11
PCT/EP2004/050280 WO2004081167A2 (en) 2003-03-11 2004-03-10 Expression vectors comprising the mcmv ie2 promoter

Publications (2)

Publication Number Publication Date
NO20054642L true NO20054642L (no) 2005-10-10
NO333818B1 NO333818B1 (no) 2013-09-23

Family

ID=32981915

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054642A NO333818B1 (no) 2003-03-11 2005-10-10 Ekspresjonsvektorer omfattende mCMV IE2 promoter, vertcelle inneholdende nevnte vektorer, anvendelses av vektorene samt fremgangsmåte for fremstilling av et polypeptid

Country Status (26)

Country Link
US (3) US7824907B2 (no)
EP (1) EP1601776B1 (no)
JP (3) JP5171033B2 (no)
KR (1) KR101180139B1 (no)
CN (1) CN100429315C (no)
AT (1) ATE399872T1 (no)
AU (1) AU2004219917B2 (no)
BR (1) BRPI0408246A (no)
CA (1) CA2516157C (no)
CY (1) CY1108344T1 (no)
DE (1) DE602004014738D1 (no)
DK (1) DK1601776T3 (no)
EA (1) EA010096B1 (no)
ES (1) ES2309508T3 (no)
HK (1) HK1085766A1 (no)
HR (1) HRP20050705B1 (no)
IL (1) IL170754A (no)
MX (1) MXPA05009608A (no)
NO (1) NO333818B1 (no)
PL (1) PL1601776T4 (no)
PT (1) PT1601776E (no)
RS (1) RS50488B (no)
SI (1) SI1601776T1 (no)
UA (1) UA88138C2 (no)
WO (1) WO2004081167A2 (no)
ZA (1) ZA200506400B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216648D0 (en) 2002-07-18 2002-08-28 Lonza Biologics Plc Method of expressing recombinant protein in CHO cells
PT1601776E (pt) * 2003-03-11 2008-09-17 Serono Lab Vectores de expressão que compreendem o promotor ie2 do mcmv
DK1622939T3 (da) * 2003-05-13 2012-04-10 Merck Serono Sa Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
EP1675956B1 (en) 2003-10-21 2010-10-13 Merck Serono SA Minimal dna sequence acting as a chromatin insulator and its use in protein expression
DK1689777T3 (da) 2003-11-05 2007-06-11 Ares Trading Sa Fremgangsmåde til oprensning af il18-bindende protein
PT1720979E (pt) 2004-03-01 2007-10-25 Ares Trading Sa Utilização de um meio de cultura de células sem soro para a produção de il-18bp em células de mamífero
DE602005009827D1 (de) * 2004-06-29 2008-10-30 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
WO2006058900A1 (en) * 2004-12-02 2006-06-08 Laboratoires Serono S.A. The lupac bifunctional marker and its use in protein production
AU2006237193B2 (en) 2005-04-22 2012-02-02 Lonza Biologics Plc. Mammalian expression vector comprising the mCMV promoter and first intron of hCMV major immediate early gene
EP1885860A2 (en) * 2005-05-16 2008-02-13 Morphotek, Inc. Regulated vectors for selection of cells exhibiting desired phenotypes
EP1885753B1 (en) * 2005-06-03 2011-07-27 Ares Trading S.A. Production of recombinant Il-18 binding protein
SI1891088T1 (sl) 2005-06-10 2012-02-29 Ares Trading Sa Postopek za äśiĺ äśenje il-18 vezavnega proteina
EP1760092A1 (en) 2005-08-26 2007-03-07 Applied Research Systems ARS Holding N.V. System for screening cells for high expression of a protein of interest
PT2227549E (pt) * 2007-12-21 2015-10-08 Novartis Ag Sistema de seleção para cultura de células eucarióticas com base num gene de recetor de folato ligado à membrana
JP2009276724A (ja) * 2008-05-19 2009-11-26 Nitto Denko Corp 光導波路装置の製造方法
PT2401377T (pt) 2009-02-27 2016-08-18 Novartis Ag Sistema de vectores de expressão compreendendo dois marcadores de selecção
JP5502406B2 (ja) * 2009-09-14 2014-05-28 ロンザ・バイオロジクス・ピーエルシー Ｃｈｏ細胞において組換えタンパク質を発現する方法
KR101038126B1 (ko) * 2010-11-30 2011-05-31 주식회사 엘지생명과학 새로운 융합 프로모터 및 이를 포함하는 재조합 벡터
US9249785B2 (en) * 2012-01-31 2016-02-02 Brightsource Industries (Isreal) Ltd. Method and system for operating a solar steam system during reduced-insolation events
ES2540753T3 (es) * 2012-09-24 2015-07-13 Lonza Biologics Plc. Vectores de expresión que comprenden secuencias quiméricas de promotor y amplificador de citomegalovirus
ITFI20120221A1 (it) * 2012-10-22 2014-04-23 Nuovo Pignone Srl "exhaust gas collector and gas turbine"
WO2014133468A1 (en) * 2013-02-28 2014-09-04 Agency For Science, Technology And Research Chimeric promoters for high gene expression level and stability in mammalian cells
CN103173481A (zh) * 2013-03-01 2013-06-26 上海中医药大学附属普陀医院 一种含有abcb1基因3′utr序列和报告基因的质粒载体及其构建方法和用途
CN103173480B (zh) * 2013-03-01 2015-06-24 上海中医药大学附属曙光医院 一种利用双荧光素酶报告基因筛选多药耐药相关microRNA的方法
EP2970956A1 (en) 2013-03-11 2016-01-20 Novartis AG Method of screening cell clones
RU2716977C2 (ru) 2013-07-31 2020-03-17 Новартис Аг Новые селективные векторы и способы селекции эукариотических клеток-хозяев
CN106029691A (zh) 2013-12-20 2016-10-12 诺华股份有限公司 用于重组表达感兴趣产物的新型真核细胞和方法
WO2015092735A1 (en) 2013-12-20 2015-06-25 Novartis Ag Novel eukaryotic cells and methods for recombinantly expressing a product of interest
JP6265020B2 (ja) * 2014-04-16 2018-01-24 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
LT3137595T (lt) 2014-04-29 2019-06-25 Novartis Ag Naujos stuburinių ląstelės ir dominančio polipeptido rekombinantinės raiškos būdai
SG11201609639VA (en) * 2014-05-19 2016-12-29 Hoffmann La Roche Method for production of polypeptides
KR20160068558A (ko) 2014-12-05 2016-06-15 삼성바이오에피스 주식회사 마우스 cmv 프로모터를 포함하는 융합 폴리뉴클레오타이드 및 이를 이용한 목적 폴리펩타이드의 생산 방법
RU2755691C2 (ru) 2015-03-05 2021-09-20 Аб2 Био Са Il-18-связывающие белок (il-18bp) и антитела при воспалительных заболеваниях
AU2016249798B2 (en) 2015-04-14 2022-05-26 Janssen Vaccines And Prevention B.V. Recombinant adenovirus expressing two transgenes with a bidirectional promoter
US11028410B2 (en) 2016-01-27 2021-06-08 Just-Evotec Biologics, Inc. Hybrid promoter and uses thereof
AU2017264562B2 (en) 2016-05-12 2023-03-09 Janssen Vaccines & Prevention B.V. Potent and balanced bidirectional promoter
EP3472327B1 (en) 2016-06-20 2020-08-19 Janssen Vaccines & Prevention B.V. Potent and balanced bidirectional promoter
KR101864581B1 (ko) * 2016-11-04 2018-07-13 국립암센터 양방향 프로모터를 포함하는 렌티바이러스 발현 벡터 및 이의 용도
JP6721797B2 (ja) 2017-02-09 2020-07-15 ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． 異種遺伝子発現のための強力で短いプロモーター
EP3692153A1 (en) 2017-10-02 2020-08-12 Astrazeneca AB Cell lines and methods for increased protein production
BR112021010785A2 (pt) * 2018-12-04 2021-11-16 Catalent Pharma Solutions Llc Vetores para fabricação de proteínas

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2007A (en) * 1841-03-16 Improvement in the mode of harvesting grain
US4963481A (en) * 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
US4968615A (en) * 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
JPS63502719A (ja) * 1985-12-18 1988-10-13 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド プロモ−タ−系
CA2318663A1 (en) * 1998-01-16 1999-07-22 California Pacific Medical Center Research Institute Methods and compositions for gene delivery
ATE511400T1 (de) * 2000-03-03 2011-06-15 Genetronics Inc Nukleinsäure-fomulierungen zur genverabreichung
MXPA02010895A (es) * 2000-05-05 2003-03-27 Applied Research Systems Uso de inhibidores de interleucina 18 para el tratamiento y/o prevencion de aterosclerosis.
US7812148B2 (en) * 2001-04-05 2010-10-12 Millipore Corporation Vectors comprising CpG islands without position effect varigation and having increased expression
US20040161817A1 (en) * 2001-06-04 2004-08-19 Corixa Corporation Compositions and methods for high-level, large-scale production of recombinant proteins
PT1601776E (pt) * 2003-03-11 2008-09-17 Serono Lab Vectores de expressão que compreendem o promotor ie2 do mcmv
DK1622939T3 (da) 2003-05-13 2012-04-10 Merck Serono Sa Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
EP1675956B1 (en) * 2003-10-21 2010-10-13 Merck Serono SA Minimal dna sequence acting as a chromatin insulator and its use in protein expression
DK1689777T3 (da) * 2003-11-05 2007-06-11 Ares Trading Sa Fremgangsmåde til oprensning af il18-bindende protein
PT1720979E (pt) 2004-03-01 2007-10-25 Ares Trading Sa Utilização de um meio de cultura de células sem soro para a produção de il-18bp em células de mamífero
DE602005009827D1 (de) 2004-06-29 2008-10-30 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
WO2006058900A1 (en) * 2004-12-02 2006-06-08 Laboratoires Serono S.A. The lupac bifunctional marker and its use in protein production
EP1885753B1 (en) 2005-06-03 2011-07-27 Ares Trading S.A. Production of recombinant Il-18 binding protein
SI1891088T1 (sl) 2005-06-10 2012-02-29 Ares Trading Sa Postopek za äśiĺ äśenje il-18 vezavnega proteina
TWI674272B (zh) * 2011-04-01 2019-10-11 中外製藥股份有限公司 具有apes活性的核酸分子

Also Published As

Publication number Publication date
US9051582B2 (en) 2015-06-09
US20150252383A1 (en) 2015-09-10
SI1601776T1 (sl) 2008-10-31
JP2015180222A (ja) 2015-10-15
RS20050687A (en) 2007-11-15
EP1601776B1 (en) 2008-07-02
IL170754A (en) 2010-11-30
UA88138C2 (en) 2009-09-25
ES2309508T3 (es) 2008-12-16
AU2004219917B2 (en) 2008-01-31
DE602004014738D1 (de) 2008-08-14
JP2006520589A (ja) 2006-09-14
MXPA05009608A (es) 2006-03-21
AU2004219917A1 (en) 2004-09-23
ZA200506400B (en) 2006-12-27
WO2004081167A3 (en) 2004-11-04
CA2516157C (en) 2012-09-18
HK1085766A1 (en) 2006-09-01
KR20050113193A (ko) 2005-12-01
NO333818B1 (no) 2013-09-23
JP5848202B2 (ja) 2016-01-27
HRP20050705B1 (hr) 2013-08-31
BRPI0408246A (pt) 2006-03-01
US7824907B2 (en) 2010-11-02
PL1601776T3 (pl) 2008-12-31
EA200501444A1 (ru) 2006-02-24
ATE399872T1 (de) 2008-07-15
CN1759184A (zh) 2006-04-12
CY1108344T1 (el) 2014-02-12
EP1601776A2 (en) 2005-12-07
RS50488B (sr) 2010-03-02
HRP20050705A2 (en) 2005-12-31
EA010096B1 (ru) 2008-06-30
PL1601776T4 (pl) 2009-05-29
PT1601776E (pt) 2008-09-17
CN100429315C (zh) 2008-10-29
WO2004081167A2 (en) 2004-09-23
US20110008839A1 (en) 2011-01-13
JP5171033B2 (ja) 2013-03-27
JP2012235787A (ja) 2012-12-06
US20070258962A1 (en) 2007-11-08
DK1601776T3 (da) 2008-10-13
KR101180139B1 (ko) 2012-09-13
CA2516157A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
NO20054642L (no) Ekspresjonsvektorer omfattende MCMV IE2 promoteren
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
TW200626171A (en) Fixed dosing of HER antibodies
EP1344827A3 (en) Antifreeze proteins from basidiomycetes
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2003074546A3 (de) Streptavidin-bindungspeptid
ATE333520T1 (de) Neuartige polynukleotide und polypeptide des ifnalpha-21 gens
WO2002068465A3 (en) Novel p53-inducible protein
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
ZA200308303B (en) Condensates for the retanning of fe-tanned leather.
ATE500338T1 (de) Verwendung des adenoviralen e2-late-promotors
HK1082510A1 (en) Promoter to il-18bp, its preparation and use
WO2003093300A3 (en) Anti-microbial peptides and compositions
FR2902101B1 (fr) Peptides a activite anti-proliferative
DE60330140D1 (de) Gen-silencing-vektor und diesen verwendendes gen-silencing-verfahren
EP1532177A4 (en) IMMUNOMODULATORY CONSTRUCTIONS AND USES THEREOF
TW200617021A (en) Isolated photoprotein aequorin y89f, and its use
TW200716177A (en) Isolated photoprotein aqdecay, and its use
TW200716666A (en) Isolated photoprotein gr-bolinopsin, and its use
TH60455B (th) โมโนเนกาไวเรลส์ไวรัสเวคเตอร์ชนิดรีคอมบิแนนท์
TH90012A (th) โมโนเนกาไวเรลส์ไวรัสเวคเตอร์ชนิดรีคอมบิแนนท์
TR200302277A2 (tr) Dağıtım otomasyon sistemi
TW200500081A (en) Novel rotaviruses and use thereof
WO2003104261A3 (en) PABLO, POLYPEPTIDE INTERACTING WITH BCL-XL, AND USES THEREOF
ITRM20050144A1 (it) Vettore adenovirale ricombinante di espressione di protein chinasi e usi relativi.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO